Clovis Oncology Inc (CLVS)

1.245 -0.06 (-4.23%) USD  |  NASDAQ  |  Oct 05, 16:00
1.25 0.00 (0.00%) After-Hours: 17:21
More

Clovis Oncology News

News

Headline
Wire
Time (ET)
Clovis Oncology's Rubraca Hits Primary Goal In Prostate Cancer Settings
Yahoo
10/03 13:35
Clovis Oncology Says Confirmatory Prostate Cancer Study of Rubraca Meets Primary Endpoint
MT Newswires
10/03 10:14
Thinking about buying stock in Myovant Sciences, Clovis Oncology, FingerMotion, LogicBio Therapeutics, or Amplify Energy?
PR Newswire
10/03 08:30
TRITON3 Phase 3 Trial of Rubraca® (rucaparib) Achieves Primary Endpoint in Men with Metastatic Castration-Resistant Prostate Cancer with BRCA or ATM Mutations
Yahoo
10/03 07:00
Clovis, Isotopia Ink Clinical Supply Pact For Lutetium-177 Used In Its Targeted Cancer Radiation Therapy
Yahoo
09/21 11:29
Clovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply Agreement
Yahoo
09/21 08:00
Clovis (CLVS) Seeks Nod for Rubraca in First Line Ovarian Cancer
Yahoo
09/14 13:09
Clovis Oncology Files Applications in US, EU for Rubraca to Treat Ovarian Cancer
MT Newswires
09/13 09:56
Thinking about buying stock in Core & Main, Catalyst Pharmaceuticals, Ironsource, Clovis Oncology, or Oncternal Therapeutics?
PR Newswire
09/13 09:31
Clovis Oncology Submits Applications for Rubraca® Label Expansion in the US and European Union as First-line Maintenance Treatment in Women with Advanced Ovarian Cancer
Yahoo
09/13 08:00
Why Clovis Oncology Zoomed 30% Higher Today
Yahoo
09/12 19:09
Thinking about buying stock in Regulus Therapeutics, Nio, AMC Entertainment, Carvana, or Clovis Oncology?
PR Newswire
09/12 09:32
Clovis Oncology's Flagship Ovarian Cancer Drug Improves Progression-Free Survival As First-Line Maintenance
Yahoo
09/12 09:11
Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk Subgroups
Yahoo
09/11 10:30
Clovis (CLVS) Down 12.6% Since Last Earnings Report: Can It Rebound?
Yahoo
09/07 11:30
The Clovis Oncology, Inc. (NASDAQ:CLVS) Analysts Have Been Trimming Their Sales Forecasts
Yahoo
08/14 08:19
OraSure, BioAtla top healthcare gainers; Singular Genomics, OptimizeRx lead losers' pack
SA Breaking News
08/10 10:02
Why Clovis Oncology Stock Is Sinking Today
Yahoo
08/08 13:37
Clovis (CLVS) Q2 Loss Wider Than Expected, Revenues Miss
Yahoo
08/08 12:42
Clovis Oncology (CLVS) Reports Q2 Loss, Misses Revenue Estimates
Yahoo
08/08 09:15
Clovis Oncology Announces Second Quarter 2022 Operating Results and Provides Update on Clinical Development Programs
Yahoo
08/08 08:00
Notable earnings before Monday's open
SA Breaking News
08/05 10:14
Will Clene Inc. (CLNN) Report Negative Q2 Earnings? What You Should Know
Yahoo
08/02 10:00
Will Clovis Oncology (CLVS) Report Negative Earnings Next Week? What You Should Know
Yahoo
08/01 10:01
7 Penny Stocks to Buy Before the Bull Market Returns
Yahoo
08/01 08:30
CORRECTING and REPLACING Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8
Yahoo
07/20 18:06
Why Clovis Oncology Stock Trounced the Market Today
Yahoo
07/19 15:43
Clovis Oncology Secures Long-Term Supply Agreement of Actinium-225 With NorthStar Medical; Shares Rise
MT Newswires
07/19 10:08
Why Clovis Oncology Stock Went Into Retreat Mode This Week
Yahoo
07/15 09:53
Thinking about buying stock in Humanigen, Endo International, Kura Oncology, Delta Air Lines, or Clovis Oncology?
PR Newswire
07/13 10:55
Why did Clovis stock jump today? Shareholders reject reverse stock split
SA Breaking News
07/08 15:57
Roku stock projected to climb 53% annually, Mastercard pauses LIV player activations
Yahoo
07/08 15:55
Clovis Oncology Shares Drop Amid Heavy Volume After Shareholders Reject Plan for a Reverse Stock Split
MT Newswires
07/08 13:40
ORMP, SRAX and RVLP among mid-day movers
SA Breaking News
07/08 12:53
Clovis Oncology climbs 34% as shareholders reject reverse stock split
SA Breaking News
07/08 12:27
Why Clovis Oncology Stock Is Crushing It Today
Yahoo
07/08 11:36
MyMD, Clovis top healthcare gainers; while RAPT, Veru lead losers' pack
SA Breaking News
07/08 10:01
Thinking about buying stock in Aprea Therapeutics, Dermata Therapeutics, Seres Therapeutics, Avadel Pharmaceuticals, or Clovis Oncology?
PR Newswire
07/08 09:31
Why Clovis Oncology Shares Jumped 158.9% in June
Yahoo
07/07 16:33
Why Clovis Oncology Stock Is Taking a Step Backward Today
Yahoo
07/07 12:27
FDA's Recommendation Before Clovis Submits Rubraca Application For Ovarian Cancer
Yahoo
07/07 07:45
Accolade, Clovis Oncology top healthcare gainers; Talaris Therapeutics leads losers
SA Breaking News
07/01 10:35
Thinking about buying stock in Axsome Therapeutics, Nio, VEON, United Airlines, or Clovis Oncology?
PR Newswire
06/30 09:31
Thinking about buying stock in Energy Focus, Ford Motor, Clovis Oncology, Li Auto, or Rigel Pharmaceuticals?
PR Newswire
06/22 09:31
Convey, Valneva top healthcare gainers; ACADIA, Comera Life lead losers' pack
SA Breaking News
06/21 10:03
HSBC, CLVS and HUT among pre market gainers
SA Breaking News
06/21 08:47
Thinking about buying stock in Clovis Oncology, Advent Technologies, DBV Technologies, Powerbridge Technologies, or Spirit Airlines?
PR Newswire
06/21 08:30
Thinking about buying stock in Clovis Oncology, Revlon, Sundial Growers, Xpeng, or Bitnile?
PR Newswire
06/15 08:30
Clovis reports early data for tumor candidate to indicate partial response
SA Breaking News
06/14 15:13
Thinking about buying stock in Clovis Oncology, Houston American Energy, Soleno Therapeutics, SeaChange International, or Norwegian Cruise Line?
PR Newswire
06/14 11:10
Top Premarket Gainers
MT Newswires
06/14 08:18
Clover Health, Aurinia Pharma among the top 10 health care additions to Russell 3000 Index, Asensus Surgical, Clovis Oncology among top deletions
SA Breaking News
06/06 11:39
Clovis Oncology downgraded to neutral at Wainwright on Rubraca ovarian cancer uncertainty
SA Breaking News
05/06 12:34
Thinking about buying stock in Vinco Ventures, Digital Brands, Endo, Clovis Oncology, or Under Armour?
PR Newswire
05/06 10:55
-- Earnings Flash (CLVS) CLOVIS ONCOLOGY Reports Q1 Loss $-0.44, vs. Street Est of $-0.49
MT Newswires
05/04 08:06
Clovis Oncology stock cools after early April surge following Rubraca ovarian cancer results
SA Breaking News
04/25 09:26
Thinking about buying stock in Citius Pharmaceuticals, BioXcel Therapeutics, Array Technologies, Gogo, or Clovis Oncology?
PR Newswire
04/06 08:31
Clovis Oncology extends two-day rally after trial win for ovarian cancer therapy
SA Breaking News
04/04 15:59
Protalix, Biophytis top healthcare gainers; while Curis, Longeveron lead losers' pack
SA Breaking News
04/04 10:02
Catalyst watch for next week: Major Bitcoin conference, Tilray earnings and Ontario iGaming/sports betting
SA Breaking News
04/01 15:00
Sector Update: Health Care Stocks Sidestep Steeper Thursday Market Losses
MT Newswires
03/31 16:07
Sector Update: Health Care Stocks Mixed in Thursday Trading
MT Newswires
03/31 14:00
Top Midday Gainers
MT Newswires
03/31 13:19
VTNR, MF and SABS among mid-day movers
SA Breaking News
03/31 12:49
Clovis Oncology Says Ovarian Cancer Treatment Met Primary Endpoint in Monotherapy Arm of Phase 3 Trial; Shares Surge
MT Newswires
03/31 11:14
Update: Wall Street Set for Flat Open; Jobless Claims Higher Than Expected
MT Newswires
03/31 09:30
Top Premarket Gainers
MT Newswires
03/31 08:07
Thinking about buying stock in Eos Energy Enterprises, Norwegian Cruise Line, Marathon Digital, Clovis Oncology, or Atreca?
PR Newswire
03/09 09:31
Clovis Oncology Q4 2021 Earnings Preview
SA Breaking News
02/22 11:20
Top 10 deletions to the MSCI US Small Cap 1750 Index during semiannual shuffle
SA Breaking News
11/12 15:07
Clovis Oncology EPS Loss Improves YoY, Misses Forecast, Revenue Drops; Shares Fall
MT Newswires
11/03 10:02
Clovis Oncology Q3 2021 Earnings Preview
SA Breaking News
11/02 11:32
Clovis Oncology Secures Lutetium-177 Supply from ITM Isotope Technologies for Cancer Drug Development
MT Newswires
10/19 09:03
--HC Wainwright Adjusts Clovis Oncology's Price Target to $9 from $10, Keeps Buy Rating
MT Newswires
09/21 08:38
Clovis Oncology's Ovarian Cancer Drug Now Reimbursable in Switzerland
MT Newswires
08/24 05:44
Clovis Oncology Renews Plan to Offer up to $125 Million Worth of Shares
MT Newswires
08/16 16:44
--HC Wainwright Adjusts Clovis Oncology's Price Target to $10 From $12, Keeps Buy Rating
MT Newswires
08/05 06:57
Clovis Oncology EPS misses by $0.04, misses on revenue
SA Breaking News
08/04 08:04
Thinking about buying stock in Cinedigm, VEON, Alcoa, Clovis Oncology, or Skillz?
PR Newswire
07/16 11:15
Thinking about buying stock in Ashford Hospitality Trust, Clovis Oncology, Exela Technologies, Wipro, or Atossa Therapeutics?
PR Newswire
07/14 09:31
VLDR, CLVS, WATT among pre-market gainers
SA Breaking News
07/14 08:32
Thinking about buying stock in Nokia, Clovis Oncology, Avinger, Ericsson, or New Oriental Education?
PR Newswire
07/13 09:31
Clovis Oncology adds Ronit Simantov to board of directors
SA Breaking News
07/12 16:15
Thinking about buying stock in Toughbuilt Industries, MER Telemanagement Solutions, United Airlines, AST SpaceMobile, or Clovis Oncology?
PR Newswire
07/12 11:30
Senseonics and Clovis Oncology gain ahead of inclusion in Russell Indexes
SA Breaking News
06/25 14:07
Clovis Oncology Opens First Clinical Site for Phase 1/2 Study of Peptide-Targeted Radionuclide Therapy
MT Newswires
06/23 08:14
Clovis starts enrollment of phase 1/2 trial for candidate to treat tumors
SA Breaking News
06/23 07:39
Asensus Surgical to join Russell Microcap Index, while Sorrento Therapeutics to see deletion
SA Breaking News
06/14 15:29
Clovis Oncology gain attributed to a policy bulletin issued by Aetna
SA Breaking News
06/14 10:14
To the moon! Deeper dive into meme stock trading
SA Breaking News
06/09 12:20
Clovis Oncology and Inovio gain amid Reddit chatter
SA Breaking News
06/09 11:17
Thinking about buying stock in The GEO Group, Orbital Energy, Clover Health, Clovis Oncology, or Energous Corp?
PR Newswire
06/09 09:31
WKHS, CLNE, GEO and CLOV among premarket gainers
SA Breaking News
06/09 08:28
Clovis Oncology Plans At-the-Market Share Offering of Up to $75 Million
MT Newswires
05/18 06:39
Clovis Oncology launches $75M at-the-market equity offering program
SA Breaking News
05/17 16:25
Clovis Oncology Q1 Loss Narrows, Revenue Declines
MT Newswires
05/05 11:17
Clovis Oncology drops 7% as Rubraca sales missed estimates amid continued COVID-19 headwinds
SA Breaking News
05/05 08:28
-- Earnings Flash (CLVS) CLOVIS ONCOLOGY Reports Q1 Loss $-0.64, vs. Street Est of $-0.68
MT Newswires
05/05 08:02
Clovis Oncology EPS beats by $0.08, misses on revenue
SA Breaking News
05/05 08:01
Clovis Oncology's Rubraca shows promise for prostate cancer in phase 1 trial
SA Breaking News
04/11 10:00
Most-shorted U.S. stocks fall after rise earlier this year on GameStop squeeze
SA Breaking News
04/03 22:36
Goldman Sachs reiterates sell for Clovis Oncology on day stock soars 48%
SA Breaking News
03/19 16:15
Seeking Alpha Catalyst Watch
SA Breaking News
03/19 15:30
Clovis Oncology Phase 3 Study Shows Improvement in Progression-Free Survival in Ovarian Cancer Patients
MT Newswires
03/19 14:59
Midday Report: Wall Street Mixed Midday, Banks Slip on End to Loose Capital Rule
MT Newswires
03/19 12:42
IDRA, CLVS, LX and MRKR among midday movers
SA Breaking News
03/19 12:42
Clovis Oncology, Marker Therapeutics leads healthcare gainers; Idera Pharmaceuticals, Praxis Precision Medicines among major losers
SA Breaking News
03/19 11:04
Thinking about buying stock in SuperCom, Clovis Oncology, Mogo Inc, Evolus, or Infinity Pharmaceuticals?
PR Newswire
03/19 09:31
MP, CLVS, SOS and TNXP among premarket gainers
SA Breaking News
03/19 08:26
Clovis Oncology stock surges as Rubraca meets ovarian cancer late-stage study main goal
SA Breaking News
03/19 08:20
Thinking about buying stock in Altimmune, Invo Bioscience, Norwegian Cruise Line, ADC Therapeutics, or Clovis Oncology?
PR Newswire
03/10 09:31
Clovis Oncology Files Up to $200 Million Mixed Shelf
MT Newswires
02/26 03:07
Thinking about buying stock in Workhorse Group, Sundial Growers, Nokia, Clovis Oncology, or Compugen?
PR Newswire
02/25 09:31
Sector Update: Health Care Stocks Mixed Near Tuesday Close
MT Newswires
02/23 15:57
Sector Update: Health Care Stocks Drifting Lower
MT Newswires
02/23 14:09
Clovis Oncology Narrows Q4 Loss, Revenue Rises
MT Newswires
02/23 09:51
Clovis Oncology shares fall after Q4 results
SA Breaking News
02/23 09:11
Thinking about buying stock in Clovis Oncology, Ashford Hospitality Trust, Atara Biotherapeutics, Sorrento Therapeutics, or Vertex Energy?
PR Newswire
01/27 09:31
AMC, BB, BBBY and GME among notable premarket gainers
SA Breaking News
01/27 08:26
Sizing up the Wall Street Bets phenomenon of retail trading
SA Breaking News
01/26 05:20
Koss nears sessions high as may be next target of Reddit WSB crew
SA Breaking News
01/25 15:33
Seeking Alpha Catalyst Watch
SA Breaking News
01/22 15:38
Clovis Oncology Projects Increase in Q4 Rubraca Revenue; Shares Climb
MT Newswires
01/11 14:41
Clovis Oncology reports preliminary Q4 Rubraca revenue between $43.0M to $43.5M
SA Breaking News
01/11 09:29
Seeking Alpha Catalyst Watch
SA Breaking News
12/31 13:30
Clovis Oncology submits FAP-2286 applications for therapeutic and imaging clinical trial
SA Breaking News
12/29 09:04
Clovis Oncology Submits Two Investigational New Drug Applications for Lead Compound in Radiotherapy Program
MT Newswires
12/29 08:26
Clovis Oncology's Late-Stage Study of Ovarian Cancer Treatment Candidate Meets Primary Endpoint
MT Newswires
12/21 11:06
Thinking about buying stock in Agios Pharmaceuticals, Clovis Oncology, Aqua Metals, Cocrystal Pharma, or Luminar Technologies?
PR Newswire
12/21 09:31
Clovis stock rises as rubraca shows survival benefit in late-stage ovarian cancer study
SA Breaking News
12/21 08:30
AJRD, AJIO, NK and LAZR among premarket gainers
SA Breaking News
12/21 08:26
Clovis Oncology's Existing Holder to Purchase Additional $7.5 Million of its New 4.50% Notes due 2024
MT Newswires
11/25 07:57
Clovis Oncology existing holder purchases additional $7.5M convertible senior notes
SA Breaking News
11/25 06:46
--Analyst Actions: SVB Leerink Adjusts Clovis Oncology's Price Target to $3 from $4, Keeps Underperform Rating
MT Newswires
11/06 13:11
--Analyst Actions: HC Wainwright Adjusts Clovis Oncology's Price Target to $15 From $23, Keeps at Buy
MT Newswires
11/06 10:06
Clovis Oncology Quarterly Loss Narrows, Revenue Rises, Company Plans to Cut Jobs, Offer $50 Million in Convertible Notes
MT Newswires
11/05 14:27
Oncternal Therapeutics, Aptevo Therapeutics leads healthcare gainers; Clovis Oncology, bluebird bio among major losers
SA Breaking News
11/05 13:13
Clovis down 21% on job cuts, convertible debt offering
SA Breaking News
11/05 13:09
ACB, BLUE, SD and UPWK among midday movers
SA Breaking News
11/05 12:43
Clovis Oncology EPS beats by $0.11, misses on revenue
SA Breaking News
11/05 08:07
Sector Watch: More oncology events as cancer ETF breaks out
SA Breaking News
09/20 09:59
Cassava Sciences, Evogene leads the healthcare gainers' pack, Ayala Pharmaceuticals, Clovis Oncology amond major losers
SA Breaking News
09/18 10:56
Clovis Oncology Says Cancer Combination Therapy Shows Anti-tumor Activity in Phase 1b Study
MT Newswires
09/17 07:45
Cancer advances ignite broad biotech and specialized ETF surge
SA Breaking News
09/15 16:12
Seeking Alpha Catalyst Watch
SA Breaking News
09/11 15:30
Clovis Oncology Announces Oral Plenary Session Presentation at International Gynecologic Cancer Society (IGCS) Digital Annual Global Meeting
Business Wire
09/10 08:05
Clovis Oncology to Highlight Data for its Three Portfolio Compounds at the ESMO Virtual Congress 2020
Business Wire
09/09 08:05
Clovis Oncology to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Business Wire
09/08 16:19
FDA OKs Roche pan-tumor liquid biopsy test
SA Breaking News
08/28 06:30
Sector Update: Health Care Stocks Advance Premarket Thursday
MT Newswires
08/27 09:20
ABT, CLVS among premarket gainers
SA Breaking News
08/27 08:21
Clovis Oncology Says FDA Approves FoundationOne Liquid CDx as Companion Diagnostic
MT Newswires
08/27 03:43
FDA OKs FoundationOne CDx as a companion Dx for Clovis Oncology's rucaparib
SA Breaking News
08/27 01:53
FDA Approves FoundationOne® Liquid CDx to Serve as Rubraca® (rucaparib) Companion Diagnostic to Identify Eligible Patients with BRCA1/2-Mutant, Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Business Wire
08/26 19:23
Thinking about buying stock in NovaBay Pharmaceuticals, RISE Education, eMagin Corp, Avinger Inc, or Clovis Oncology?
PR Newswire
08/18 09:31
Clovis up 20% on rucaparib data in prostate cancer
SA Breaking News
08/17 14:23
Clovis Oncology among healthcare gainers; Unity Biotechnology leads the losers
SA Breaking News
08/17 11:04
Stocks Edge Mostly Higher as S&P 500 Moves to Record High, Dow Fluctuates in Early US Trading
MT Newswires
08/17 10:01
Clovis Oncology Says Rubraca Shows Significant Clinical Activity in Men With a Certain Type of Prostate Cancer
MT Newswires
08/17 09:02
Journal of Clinical Oncology Publishes Additional Data from Clovis Oncology’s TRITON2 Clinical Trial Evaluating Rubraca® (rucaparib) for the Treatment of mCRPC in Patients with BRCA1/2 Gene Mutations
Business Wire
08/17 08:05
--Analyst Actions: RBC Capital Trims Clovis Oncology's Price Target to $16 From $17, Keeps Outperform-Speculative Risk Rating
MT Newswires
08/07 07:44
Clovis Oncology Announces Second Quarter 2020 Operating Results
Business Wire
08/06 16:05
Clovis launches mid-stage study of lucitanib in gynecologic cancers
SA Breaking News
08/05 08:59
Clovis Oncology Announces First Patient Enrolled in the Phase 2 Portion of the LIO-1 Trial Evaluating the Combination of Lucitanib and Opdivo in Gynecologic Cancers
Business Wire
08/05 08:05
Clovis Oncology to Announce Second Quarter 2020 Financial Results and Host Webcast Conference Call on August 6
Business Wire
07/23 08:00
Alkermes, Clovis Oncology Pre-Clinical Study Supports Potential of Colon Cancer Combination Therapy
MT Newswires
06/22 11:08
New Preclinical Data on ALKS 4230 in Combination With Lucitanib to be Presented at 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II
PR Newswire
06/22 09:01
Clovis Oncology to Highlight Rubraca® (rucaparib) and Lucitanib Non-Clinical Data at the AACR Virtual Annual Meeting II 2020
Business Wire
06/17 08:00
Clovis Oncology Completes Target Enrollment in Late-Stage Trial for Advanced Ovarian Cancer - Stock Up 1% After-Hours
MT Newswires
06/10 17:03
Clovis completes enrollment in study of Rubraca combo in ovarian cancer
SA Breaking News
06/10 16:21
Clovis Oncology Announces Completion of Target Enrollment in the ATHENA Trial, a Phase 3 Maintenance Treatment Study in Front-line, Newly-Diagnosed Advanced Ovarian Cancer
Business Wire
06/10 16:05
Clovis Oncology' Rubraca Added to Guidelines as Treatment for Metastatic Castration-Resistant Prostate Cancer
MT Newswires
05/28 11:51
Cancer treatment guidelines add new recommendations for Clovis' Rubraca
SA Breaking News
05/28 08:41
Clovis Oncology Announces New Recommendations for Rubraca® (rucaparib) Tablets in Updated National Comprehensive Cancer Network (NCCN) Guidelines® for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Business Wire
05/28 08:00
Analyst Actions: HC Wainwright Cuts Clovis Oncology's Price Target to $29 From $33, Reiterates Buy Rating
MT Newswires
05/22 11:32
Clovis Oncology Announces Presentations at 2020 ASCO Virtual Scientific Program
Business Wire
05/21 16:10
Analyst Actions: SVB Leerink Cuts Price Target on Clovis Oncology to $4 From $5, Keeps Underperform Rating
MT Newswires
05/20 09:28
SAN, CVNA among premarket losers
SA Breaking News
05/19 09:13
Clovis Oncology Prices Common Stock Offering At $8.05 A Share
MT Newswires
05/19 06:04
Clovis Oncology down 9% after pricing stock offering
SA Breaking News
05/19 04:39
Clovis Oncology Announces Pricing of Public Offering of Common Stock
Business Wire
05/18 20:05
ACB, BIDU, IQ and CLVS among after-hours movers
SA Breaking News
05/18 17:37
Clovis launches $85M stock offering
SA Breaking News
05/18 16:10
Clovis Oncology Plans to Sell $85 Million in Stock - Shares Drop 5% After-Hours
MT Newswires
05/18 16:09
Clovis Oncology Announces Proposed Offering of Common Stock
Business Wire
05/18 16:02
Analyst Actions: HC Wainwright Lifts Clovis Oncology's Price Target to $33 From $29, Reiterates Buy Rating
MT Newswires
05/18 09:21
FDA OKs expanded use of Clovis' rucaparib
SA Breaking News
05/15 15:36
Clovis Oncology Lands USFDA's Nod for Use of Rubraca to Treat Prostate Cancer
MT Newswires
05/15 15:27
Rubraca® (Rucaparib) Approved in the U.S. as Monotherapy Treatment for Patients with BRCA1/2-Mutant, Metastatic Castration-Resistant Prostate Cancer (mCRPC) Who Have Been Treated with Androgen Receptor-Directed Therapy and a Taxane-Based Chemotherapy
Business Wire
05/15 14:30
Analyst Actions: HC Wainwright Lifts Price Target on Clovis Oncology to $29 From $27, Reiterates Buy Rating
MT Newswires
05/06 10:04
GM, ATVI among premarket gainers
SA Breaking News
05/06 09:23
Clovis Oncology Announces First Quarter 2020 Operating Results
Business Wire
05/05 16:05
CGC, STWD among premarket gainers
SA Breaking News
05/04 09:13
Clovis Oncology to Present at the Bank of America Health Care Conference 2020
Business Wire
04/29 16:05
--Analyst Actions: SVB Leerink Downgrades Clovis Oncology to Underperform From Market Perform, Drops PT to $5 From $10
MT Newswires
04/27 09:42
Clovis down 3% premarket as Leerink cuts view
SA Breaking News
04/27 06:52
Clovis Oncology to Announce First Quarter 2020 Financial Results and Host Webcast Conference Call on May 5
Business Wire
04/21 16:05
Clovis Oncology launches debt exchange offer
SA Breaking News
04/15 07:17
Clovis Oncology Exchanges Some of 2.5% of 2021 Convertibles Debt with 4.5% of 2024 Notes
MT Newswires
04/14 17:52
MT Newswires After-Hours News Movers
MT Newswires
04/14 17:47
Clovis Oncology Announces Debt Exchange Transaction
Business Wire
04/14 17:08
Analyst Actions: BofA Securities Downgrades Clovis Oncology to Underperform From Neutral; Price Target is $6
MT Newswires
04/09 10:39
Evercore bearish on medical device makers in premarket analyst action
SA Breaking News
04/09 07:32
DAL, INO, TEN and SGMS among after-hours movers
SA Breaking News
04/03 17:43
FCAU, HLT among premarket losers
SA Breaking News
03/19 09:23
Clovis Oncology to Present at the Barclays Global Healthcare Conference
Business Wire
03/03 08:30
Clovis Oncology Announces Availability and Reimbursement for Rubraca® (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in Spain
Business Wire
03/02 04:00
ABEV, PLAN among premarket losers
SA Breaking News
02/27 09:17
Close Update: Stocks Suffer Further Decline Amid Continued Coronavirus Spread; CDC Says US Outbreak Seems 'Inevitable'
MT Newswires
02/25 16:52
Midday Report: US Stocks Plunge, 10-Year Yield Touches Record Low as Widening Coronavirus Footprint Spooks Investors
MT Newswires
02/25 13:56
Mallinckrodt among healthcare gainers; Tocagen and Clovis Oncology among losers
SA Breaking News
02/25 11:03
--Analyst Actions: RBC Tacks 'Speculative Risk' Onto Clovis Oncology's Outperform Rating, Citing Convertible Debt; Price Target Remains $17
MT Newswires
02/25 09:14
MT Newswires After-Hours News Movers
MT Newswires
02/24 17:53
Clovis -8.1% after worse-than-expected Q4 loss
SA Breaking News
02/24 17:18
Clovis Oncology Q4 Per-Share Loss Worse Than Estimates; Revenue Exceeds -- Shares Slips 8% After Market Close
MT Newswires
02/24 17:16
Clovis Oncology Announces 2019 Operating Results
Business Wire
02/24 16:05
Earnings Reaction History: Clovis Oncology Inc, 44.4% Follow-Through Indicator, 9.3% Sensitive
MT Newswires
02/24 13:58
Clovis Oncology to Announce Fourth Quarter/Full Year 2019 Financial Results and Host Webcast Conference Call on February 24
Business Wire
02/13 08:30
Clovis Oncology to Present at the 9th Annual SVB Leerink Healthcare Conference
Business Wire
02/11 16:05
Clovis Oncology's Rubraca now available in France; shares up 4% premarket
SA Breaking News
02/03 08:44
Clovis Oncology Launches Ovarian Cancer Drug in France
MT Newswires
02/03 05:51
Clovis Oncology Announces Availability and Reimbursement for Rubraca® (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in France
Business Wire
02/03 04:00
Analyst Actions: BofA Securities Raises Price Target for Clovis Oncology to $10 From $7, Maintains Neutral Rating
MT Newswires
01/23 14:06
Close Update: Market Indexes Hit New Intraday Highs; US, China Sign Initial Trade Deal; Dow Surpasses 29,000-Mark on Close
MT Newswires
01/15 16:45
Midday Update: Stocks Climb Ahead of Trump Signing Interim Trade Deal With China
MT Newswires
01/15 12:32
Healthcare - Top 5 Gainers / Losers
SA Breaking News
01/15 11:01
Wall Street Wavers Pre-Bell Before US, China Sign Trade Deal
MT Newswires
01/15 09:14
NIO, NVAX among premarket gainers
SA Breaking News
01/15 09:12
Clovis Oncology Says Rubraca Wins FDA Priority Review for Advanced Prostate Cancer; Shares Jump Pre-Bell
MT Newswires
01/15 08:27
FDA accepts Clovis application for new use of Rubraca; shares up 13% premarket
SA Breaking News
01/15 08:14
Clovis Oncology’s Rubraca® (rucaparib) Granted FDA Priority Review for Advanced Prostate Cancer
Business Wire
01/15 08:00
Analyst Actions: HC Wainwright Cuts Clovis Oncology Price Target to $27 From $36, Maintains Buy Rating
MT Newswires
01/08 12:14
Advaxis among healthcare gainers, Cassava Sciences leads the losers
SA Breaking News
01/07 11:02
Clovis Oncology Anticipates Higher Rubraca Product Revenue in Q4 2019
MT Newswires
01/07 09:42
Clovis Oncology announces debt refinancing
SA Breaking News
01/07 08:25
Clovis Oncology sees Rubarca revenue as high as $143M in FY 2019
SA Breaking News
01/07 08:02
Clovis Oncology Announces Debt Refinancing Transaction
Business Wire
01/07 07:26
Clovis Oncology Announces Product Revenues for the Fourth Quarter and Full Year 2019
Business Wire
01/07 07:25
UL, CLVS among premarket losers
SA Breaking News
12/17 09:12
Clovis Oncology's FAP-2286 Used for Named-Patients in Germany, Shows Consistency With Standard of Care
MT Newswires
12/17 08:00
Clovis Oncology Files $250 Million Mixed Shelf
MT Newswires
12/17 03:17
Clovis Oncology files for $250M mixed shelf; shares down 12%
SA Breaking News
12/16 20:17
Initial Clinical Experience Reported from FAP-2286 Named-Patient Use at ICPO Symposium
Business Wire
12/16 08:30
Clovis Oncology among healthcare gainers; Curis among losers
SA Breaking News
12/06 11:06
CLVS, AUPH, ESTC and HOV among midday movers
SA Breaking News
12/05 12:41
Aurinia Pharmaceuticals leads healthcare gainers; Sage Therapeutics leads the losers
SA Breaking News
12/05 11:00
GPRO, CLVS among premarket gainers
SA Breaking News
12/04 09:11
Thinking about buying stock in Aurora Cannabis, Advanced Micro Devices, Clovis Oncology, Facebook, or AT&T?
PR Newswire
12/02 09:31
SKT, CLVS among premarket gainers
SA Breaking News
12/02 09:22
Healthcare - Top 5 Gainers / Losers
SA Breaking News
11/29 10:34